CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $6,669,998
- in 2 filings, $6.7M under 10b5-1 plans
Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Taub Rebecca Director | Grant or award | +454 | 452,667 | ||
| 2026-06-17 | Taub Rebecca Director | Grant or award · Stock Option (Right to Buy) | +766 | 766 | ||
| 2026-03-06 | Taub Rebecca Director | Sale | −491 | $431.94 | $212K | 452,213 |
| 2026-01-26 | Taub Rebecca Director | Sale | −647 | $492.42 | $319K | 452,704 |
| 2026-01-20 | Taub Rebecca Director | Sale | −2,238 | $490.77 | $1.1M | 453,351 |
| 2026-01-09 | Taub Rebecca Director | Exercise or conversion 10b5-1 | +240 | $15.80 | $4K | 455,829 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −40 | $545.79 | $22K | 455,789 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −200 | $551.24 | $110K | 455,589 |
| 2026-01-09 | Taub Rebecca Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −240 | 0 | ||
| 2026-01-09 | Taub Rebecca Director | Exercise or conversion 10b5-1 | +18,410 | $15.80 | $291K | 473,999 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −960 | $512.02 | $492K | 473,039 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −960 | $513.12 | $493K | 472,079 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −937 | $514.63 | $482K | 471,142 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −1,578 | $515.82 | $814K | 469,564 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −521 | $516.81 | $269K | 469,043 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −2,044 | $517.84 | $1.1M | 466,999 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −970 | $518.67 | $503K | 466,029 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −539 | $519.89 | $280K | 465,490 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −440 | $521.11 | $229K | 465,050 |
| 2026-01-09 | Taub Rebecca Director | Sale 10b5-1 | −588 | $521.95 | $307K | 464,462 |
Page 1 of 7 · 139 trades